Screener
Denali Therapeutics Inc. DNLI Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue: | ||||
| Product revenue, net | $3,604 | — | $3,604 | — |
| Total revenue | 3,604 | — | 3,604 | — |
| Operating expenses: | ||||
| Cost of goods sold | 93 | — | 93 | — |
| Research and development | 97,019 | 102,696 | 200,865 | 218,923 |
| Selling, general and administrative | 36,283 | 32,267 | 69,794 | 61,620 |
| Intangible asset amortization | 750 | — | 750 | — |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Denali Therapeutics Inc.'s total revenue?
- Denali Therapeutics Inc. (DNLI) reported total revenue of $3.6M in Q2 2026.
- What is the long-term trend for Denali Therapeutics Inc.'s total revenue?
- Over 3 years (2021 to 2024), Denali Therapeutics Inc.'s total revenue has grown at a -100.0% compound annual growth rate (CAGR), from $48.66M to $0.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Denali Therapeutics Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude